Medicine's David Bajor explains changing cancer screening guidelines

Common drug halves recurrence of colorectal cancer

The Epoch Times: David Bajor, assistant professor of medicine and member at the Case Comprehensive Cancer Center, explained that previously, doctors had only tested patients with stage 4 disease for PIK3CA mutations, but now it is recommended to test patients with stages 2 and 3 as well. The study has already “changed our guidelines [at our cancer center] to indicate genetic testing for this mutation in a population we previously weren’t doing genetic testing on,” said Bajor.